Ionis Pharmaceuticals, Inc.
IONSBiotechnology
$43.52−1.96%As of Oct 30vs prior close
- Market cap
- $7.2B
- P/E (TTM)
- –
- From 52W high
- −49.69%
- EPS (LTM)
- -$3.40
- Revenue (LTM)
- $874.1M
- Net margin
- -64.66%
- Dividend yield
- 0.00%
Nomior Score
41
Steady ProfileSpeculativeBottom 31% of the scored universe
Growth56
Quality54
Value53
Momentum12
Resilience54
Growth
+10.87%revenue a year over 9 fiscal years
YE16 $372.8MLTM $874.1M
Connections
Revenue to profitQ2 YE26
The operating loss was 38% of revenue, wider by 69 pts on a year.
Who owns it
1fund, 1 tracked portfolio